AU2003209533A1 - Process of manufacturing pharmaceutical composition useful for management of tuberculosis - Google Patents

Process of manufacturing pharmaceutical composition useful for management of tuberculosis

Info

Publication number
AU2003209533A1
AU2003209533A1 AU2003209533A AU2003209533A AU2003209533A1 AU 2003209533 A1 AU2003209533 A1 AU 2003209533A1 AU 2003209533 A AU2003209533 A AU 2003209533A AU 2003209533 A AU2003209533 A AU 2003209533A AU 2003209533 A1 AU2003209533 A1 AU 2003209533A1
Authority
AU
Australia
Prior art keywords
tuberculosis
management
pharmaceutical composition
composition useful
manufacturing pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003209533A
Other versions
AU2003209533A8 (en
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003209533A1 publication Critical patent/AU2003209533A1/en
Publication of AU2003209533A8 publication Critical patent/AU2003209533A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003209533A 2002-03-08 2003-03-04 Process of manufacturing pharmaceutical composition useful for management of tuberculosis Abandoned AU2003209533A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN236MU2002 2002-03-08
IN236/MUM/2002 2002-03-08
PCT/IB2003/000801 WO2003075824A2 (en) 2002-03-08 2003-03-04 Process of manufacturing pharmaceutical composition useful for management of tuberculosis

Publications (2)

Publication Number Publication Date
AU2003209533A1 true AU2003209533A1 (en) 2003-09-22
AU2003209533A8 AU2003209533A8 (en) 2003-09-22

Family

ID=27799868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003209533A Abandoned AU2003209533A1 (en) 2002-03-08 2003-03-04 Process of manufacturing pharmaceutical composition useful for management of tuberculosis

Country Status (5)

Country Link
JP (1) JP2005519941A (en)
KR (1) KR20050008453A (en)
AU (1) AU2003209533A1 (en)
BR (1) BR0303367A (en)
WO (1) WO2003075824A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
BR0307262A (en) * 2002-01-29 2006-12-19 Bakulesh Mafatlal Khamar Method of Providing Tuberculosis Prophylaxis in HIV-Positive Individuals
WO2008114119A2 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
HUE024427T2 (en) * 2007-04-12 2016-01-28 Mico Bio Inc Tuberculosis vaccine and method of using same
CA2691702A1 (en) * 2007-06-28 2008-12-31 Cadila Pharmaceuticals Ltd. Mitogen activated protein kinase modulator
FR2979826B1 (en) * 2011-09-08 2013-12-27 Univ Bordeaux Segalen ANTI-INFLAMMATORY COMPOSITION
KR101696514B1 (en) * 2014-08-18 2017-01-24 서울대학교산학협력단 Temperature Sensitive Mycobacterial strain and its use as vaccine against mycobacterial infection disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567585A (en) * 1963-07-12 1971-03-02 Ciba Geigy Corp Process for obtaining bcg-cultures
JPS4843842B1 (en) * 1970-07-17 1973-12-21

Also Published As

Publication number Publication date
KR20050008453A (en) 2005-01-21
BR0303367A (en) 2004-07-20
WO2003075824A3 (en) 2003-12-24
WO2003075824A2 (en) 2003-09-18
AU2003209533A8 (en) 2003-09-22
JP2005519941A (en) 2005-07-07

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003250372A1 (en) Pharmaceutical composition
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2003269126A1 (en) Method of combining materials
AU2003241671A1 (en) Controlled-release drug composition
AU2002353366A1 (en) The process of manufacturing a pharmaceutical composition useful for management of cancer
AU2002361132A1 (en) Plasticine composition and process for production thereof
AU2003209533A1 (en) Process of manufacturing pharmaceutical composition useful for management of tuberculosis
AU2003231920A1 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
AU2003287996A1 (en) Filled-cavity tablets and method for their production
AU2003275585A1 (en) Wax composition and method for production thereof
AU2003286944A1 (en) Crude drug compositions and the process for preparing them
AU2003282375A1 (en) Pharmaceutical compositions and process of production thereof
AU2003245033A1 (en) An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation
AU2003261766A1 (en) Process for production of 4-alkylphenols
AU2003225745A1 (en) Free-base formulations of local anesthetics
AU2003284545A1 (en) Novel intermediate for carbapenem compound for oral administration and process for producing the same
AU2003284546A1 (en) Process for producing carbapenem compound for oral administration
AU2003292820A1 (en) 4-amino-5-methylpyrazole derivatives and process for production thereof
AU2003243432A1 (en) Process of making phosphordiamidite compounds
AU2003258593A1 (en) Organophosphorous compounds for the treatment of helminthic infections
AU2003207196A1 (en) PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE Beta-PHENYLALANINE
AU2002351693A1 (en) Use of a kmo inhibitor for producing a pharmaceutical composition
AU2003235129A1 (en) Process for preparation of 2-aminoketones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase